-
Review
September 27, 2021
- The role of transjugular intrahepatic portosystemic shunt in patients with portal hypertension: Advantages and pitfalls
- Hae Lim Lee, Sung Won Lee
- Clin Mol Hepatol. 2022;28(2):121-134.
Review
September 27, 2021
Review
October 22, 2021
Review
November 10, 2021
Review
December 27, 2021
Original Article
November 28, 2021
Original Article
January 13, 2022
Original Article
November 24, 2021
Original Article
July 20, 2021
Original Article
January 5, 2022
Original Article
February 7, 2022
Original Article
December 28, 2021
This archive contains links to the full-text of all issues of Clin Mol Hepatol.
![]() |
First decision
09 Days
Publication after acceptance
04 Days
*Last 12 months
Viewed By 8443 |
Association between serum tumor necrosis factor-α and sarcopenia in liver cirrhosis |
Viewed By 3906 |
Letter: cervicocerebral atherosclerosis and its hepatic and coronary risk factors in patients with liver cirrhosis |
Viewed By 3655 |
KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease |
Viewed By 2679 |
KASL clinical practice guidelines for liver cirrhosis: Varices, hepatic encephalopathy, and related complications |
Viewed By 2213 |
Predictors of steroid non-response and new approaches in severe alcoholic hepatitis |
Cited By 43 |
Trends in the prevalence of chronic liver disease in the Korean adult population, 1998–2017 |
Cited By 32 |
Application of transient elastography in nonalcoholic fatty liver disease |
Cited By 29 |
Novel biomarkers for the management of chronic hepatitis B |
Cited By 29 |
Comparison of clinical practice guidelines for the management of chronic hepatitis B: When to start, when to change, and when to stop |
Cited By 28 |
Unmet needs of chronic hepatitis C in the era of direct-acting antiviral therapy |